Skip to main content

Day: March 24, 2020

BALMORAL TEMPORARILY SUSPENDS EXPLORATION ACTIVITIES IN QUEBEC AND ONTARIO IN RESPONSE TO COVID-19 ORDERS

VANCOUVER, British Columbia, March 24, 2020 (GLOBE NEWSWIRE) — Balmoral Resources Ltd. (“Balmoral” or the “Company”) (TSX: BAR; OTCQX: BALMF) announced today, following the orders of the Governments of Quebec and Ontario in response to the COVID-19 pandemic, that it has, effective immediately, suspended until further notice its exploration activities in both provinces.Balmoral’s head office in Vancouver was closed in response to the concerns around COVID-19 on March 12, 2020, with all staff requested to work remotely since that time. To date Balmoral, and Wallbridge Mining Company Limited (“Wallbridge”) with whom Balmoral shares the Fenelon exploration camp in Quebec, have reported no suspected or confirmed cases of COVID-19. The parties have had in place COVID-19 protocols to protect the workforce currently in camp.“The health...

Continue reading

NexTech AR Integrates Zoom Video Conferencing Into Remote Work & Learning Platform

NEW YORK and TORONTO, March 24, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), the leader in augmented reality for eCommerce and AR learning applications, is pleased to announce that it has integrated Zoom (NYSE: ZM) into Jolokia’s Inferno platform extending the capabilities of Zoom meetings out to 100,000 people concurrently with real-time Q&A Plus immersive AR creating a one of a kind new platform. NexTech has a binding LOI to acquire remote video training, live streaming software company Jolokia; whose blue-chip customers include Merck, Toyota Viacom CBS, Polycom and others.What the Inferno – Zoom meetings integration meansNow, you can extend the value of your Zoom meetings out to 100,000 people concurrently with Q&A on the Inferno Platform, amplify your video experiences...

Continue reading

ImprimisRx® Announces Exclusive Agreement with Doxy.me to Provide Healthcare Professionals with Telemedicine Services

NASHVILLE, Tenn., March 24, 2020 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) and ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow, announced that they have entered into an exclusive agreement with Doxy.me, a full-service telemedicine solution. This agreement will provide all ImprimisRx ophthalmology, optometry, and wellness practices with the Clinic level Doxy.me telemedicine solution at no charge. Doxy.me is one of the largest, yet simplest, telemedicine software solutions in the world, providing video, audio and text through which patients and healthcare providers can seamlessly communicate remotely.Mark L. Baum, CEO of Harrow Health, said, “ImprimisRx was founded on the principles of innovation and always putting patients...

Continue reading

Maersk Drilling receives notice of contract termination for Maersk Venturer

Today, The Drilling Company of 1972 A/S (“Maersk Drilling”) announces that it has received a notification from Tullow Ghana Ltd. (“Tullow”) of early termination for convenience of the drilling contract for the drillship Maersk Venturer.Since February 2018, Maersk Venturer has worked for Tullow offshore Ghana with an expected end of contract in February 2022. The rig is now expected to end the contract in June 2020. As a consequence of the termination, Maersk Drilling’s revenue contract backlog is reduced by USD 175m covering the period from the end of the contract to February 2022.Subject to commercial prospects, Maersk Drilling will take measures to reduce Maersk Venturer’s operating costs following the end of the contract.Maersk Drilling maintains the profitability guidance for 2020 of EBITDA before special items of USD 325-375m as...

Continue reading

Indberetning af fejlberegning af indre værdi for Investeringsforeningen PFA Invest, afdeling Danske Aktier

      Der er den 23. marts 2020 konstateret, at der er fejl i beregningen af indre værdi i Investeringsforeningen PFA Invest, afdeling Danske Aktier, der har medført at afdelingens indre værdi i perioder har afveget med mere end 0,5 %.Nedenfor er en oversigt over afvigelserne til indre værdi med den relevante periode angivet. Udover denne meddelelse, er der foretaget underretning til foreningens depotselskab, samt børsmæglerforeningens medlemmer, med henblik på kontakt til de berørte kunder for en korrektion af indgåede handler.Med venlig hilsenPFA Asset Management A/S

Continue reading

ARCH BIOPARTNERS DISCLOSES NEW PATENT FILING FOR NOVEL DRUG CANDIDATES TO PREVENT LUNG INFLAMMATION

TORONTO, March 24, 2020 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) a clinical stage company developing new drug candidates for treating organ damage caused by inflammation, announced today it has filed a new provisional patent application with the U.S. Patent and Trademark Office entitled, “Lung Endothelial Binding Agents And Methods Of Use” to protect new drug candidates that reduce lung inflammation.This provisional patent application protects compositions and the method of use for novel drug molecules designed to inhibit lung inflammation in the context of bacterial and viral pneumonia. The compositions target distinct pathways independent from Arch Biopartners’ lead drug candidate Metablok (LSALT peptide), providing additional capability to reduce lung inflammation...

Continue reading

QIWI Announces Fourth Quarter and Full Year 2019 Financial Results

Fourth Quarter Total Adjusted Net Revenue Increases 7% to RUB 6,253 Million and Adjusted Net Profit Increases 15% to RUB 1,168 Million or RUB 18.74 per diluted shareFull-Year 2019 Total Adjusted Net Revenue Increases 18% to RUB 23,176 Million and Adjusted Net Profit Increases 61% to RUB 6,679 Million or RUB 107.27 per diluted shareQIWI gives 2020 GuidanceBoard of Directors Approves Dividend Payout Ratio for 2020NICOSIA, Cyprus, March 24, 2020 (GLOBE NEWSWIRE) — QIWI plc (NASDAQ: QIWI) (MOEX: QIWI) (“QIWI” or the “Company”) today announced results for the fourth quarter and full year ended December 31, 2019.Fourth Quarter 2019 Operating and Financial Highlights

Continue reading

Surna Reports Q4 2019 and Full Year Results

Announces $15.2 Million in 2019 Revenue andDownsizing of Operations in Response to CoronavirusBoulder, Colorado, March 24, 2020 (GLOBE NEWSWIRE) — Surna Inc. (OTCQB: SRNA) announced today operating and financial results for the three and 12 months ended December 31, 2019.Due to the unprecedented circumstances surrounding the COVID-19 virus and the uncertainty of its impact on the Company’s operations, the Company has decided to cancel its Q4 2019 investor conference call previously scheduled for March 26, 2020.Financial Highlights1 “Adjusted net income (loss)” means our GAAP net income (loss), after adjustment for non-cash equity compensation expense, debt-related items and depreciation expense.Downsizing of OperationsA number of recent events have had an adverse impact on our operations and financial condition, including constraints...

Continue reading

VSBLTY ANNOUNCES KLA LABORATORIES PARTNERSHIP

Philadelphia, PA, March 24, 2020 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC:VSBGF) (“VSBLTY”), a leading retail software technology company, today announced that it is partnering with KLA Laboratories, Inc. in the KLArity Ecosystem Partners Platform, which was created to enable KLA to help their customers navigate the landscape of emerging technologies and the integration of those solutions in their respective environments and facilities.In announcing the partnership with KLA, a 91-year-old family-owned firm providing a range of information technology and communication projects and services, VSBLTY Co-founder and CEO, Jay Hutton said, “Our entire team is excited to partner with industry leader KLA Laboratories, whose solutions enable their customers to stay ahead of the curve as the technology...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.